Structural Context of a Critical Exon of Spinal Muscular Atrophy Gene

被引:12
作者
Singh, Natalia N. [1 ]
O'Leary, Collin A. [2 ]
Eich, Taylor [2 ]
Moss, Walter N. [2 ]
Singh, Ravindra N.
机构
[1] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA
[2] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA
基金
美国国家卫生研究院;
关键词
RNA structure; splicing; small molecule; spinal muscular atrophy; SMA; survival motor neuron; SMN; ISS-N1; SURVIVAL-MOTOR-NEURON; SPLICING ENHANCER; RNA STRUCTURE; REVERSE TRANSCRIPTASE/MATURASE; INTRONIC STRUCTURE; SINGLE NUCLEOTIDE; SMALL-MOLECULE; MOUSE MODEL; SMN2; ELEMENT;
D O I
10.3389/fmolb.2022.928581
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Humans contain two nearly identical copies of Survival Motor Neuron genes, SMN1 and SMN2. Deletion or mutation of SMN1 causes spinal muscular atrophy (SMA), one of the leading genetic diseases associated with infant mortality. SMN2 is unable to compensate for the loss of SMN1 due to predominant exon 7 skipping, leading to the production of a truncated protein. Antisense oligonucleotide and small molecule-based strategies aimed at the restoration of SMN2 exon 7 inclusion are approved therapies of SMA. Many cis-elements and transacting factors have been implicated in regulation of SMN exon 7 splicing. Also, several structural elements, including those formed by a long-distance interaction, have been implicated in the modulation of SMN exon 7 splicing. Several of these structures have been confirmed by enzymatic and chemical structure-probing methods. Additional structures formed by inter-intronic interactions have been predicted by computational algorithms. SMN genes generate a vast repertoire of circular RNAs through inter-intronic secondary structures formed by inverted Alu repeats present in large number in SMN genes. Here, we review the structural context of the exonic and intronic cis-elements that promote or prevent exon 7 recognition. We discuss how structural rearrangements triggered by single nucleotide substitutions could bring drastic changes in SMN2 exon 7 splicing. We also propose potential mechanisms by which inter-intronic structures might impact the splicing outcomes.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] History of development of the life-saving drug "Nusinersen" in spinal muscular atrophy
    Qiu, Jiaying
    Wu, Liucheng
    Qu, Ruobing
    Jiang, Tao
    Bai, Jialin
    Sheng, Lei
    Feng, Pengchao
    Sun, Junjie
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [42] Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy
    Wadman, Renske, I
    Jansen, Marc D.
    Stam, Marloes
    Wijngaarde, Camiel A.
    Curial, Chantall A. D.
    Medic, Jelena
    Sodaar, Peter
    Schouten, Jan
    Vijzelaar, Raymon
    Lemmink, Henny H.
    van den Berg, Leonard H.
    Groen, Ewout J. N.
    van der Pol, W. Ludo
    BRAIN COMMUNICATIONS, 2020, 2 (02)
  • [43] Spinal Muscular Atrophy: Molecular Mechanisms
    Farrar, M. A.
    Johnston, H. M.
    Grattan-Smith, P.
    Turner, A.
    Kiernan, M. C.
    CURRENT MOLECULAR MEDICINE, 2009, 9 (07) : 851 - 862
  • [44] Spinal muscular atrophy: The role of SMN in axonal mRNA regulation
    Fallini, Claudia
    Bassell, Gary J.
    Rossoll, Wilfried
    BRAIN RESEARCH, 2012, 1462 : 81 - 92
  • [45] Spinal Muscular Atrophy Therapeutics: Where do we Stand?
    d'Ydewalle, Constantin
    Sumner, Charlotte J.
    NEUROTHERAPEUTICS, 2015, 12 (02) : 303 - 316
  • [46] How far away is spinal muscular atrophy gene therapy?
    Gillingwater, Thomas H.
    Murray, Lyndsay M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (09) : 965 - 968
  • [47] Prospects for the gene therapy of spinal muscular atrophy
    Passini, Marco A.
    Cheng, Seng H.
    TRENDS IN MOLECULAR MEDICINE, 2011, 17 (05) : 259 - 265
  • [48] Applicability of Histone Deacetylase Inhibition for the Treatment of Spinal Muscular Atrophy
    Lunke, Sebastian
    El-Osta, Assam
    NEUROTHERAPEUTICS, 2013, 10 (04) : 677 - 687
  • [49] Spinal muscular atrophy: Molecular mechanism of pathogenesis, diagnosis, therapeutics, and clinical trials in the Indian context
    Aasdev, Ashutosh
    Sreelekshmi, R. S.
    Iyer, V. Rajesh
    Moharir, Shivranjani C.
    JOURNAL OF BIOSCIENCES, 2024, 49 (01)
  • [50] New and developing therapies in spinal muscular atrophy
    Kariyawasam, Didu
    Carey, Kate A.
    Jones, Kristi J.
    Farrar, Michelle A.
    PAEDIATRIC RESPIRATORY REVIEWS, 2018, 28 : 3 - 10